Omzo vs Hers: Compounded Semaglutide vs Brand-Name Wegovy Compared
Quick verdict: Omzo focuses on clinician-guided, personalized compounded semaglutide starting at $179 and may provide prescriptions for branded meds; Hers offers FDA-approved Wegovy and other brand-name GLP-1s from $149/mo with a required membership for medication access. Choose based on whether you prefer compounded options or FDA-approved brand-name therapy.
When comparing Omzo vs Hers the central difference is product type and pricing model. Omzo centers on personalized compounded semaglutide, clinician-guided, starting at $179. Hers emphasizes FDA-approved Wegovy and other brand-name GLP-1s from $149/month and requires a membership for medication access.
Explore Omzo clinician-guided plans
Key differences at a glance: compounded program versus FDA-approved brands
Omzo and Hers both offer clinician oversight but differ most on three main points: medication type and regulatory status, pricing and membership structure, and ongoing care features. Those differences drive the rest of this comparison.
1. Medication type and regulatory status
Omzo: The Omzo platform connects users with licensed medical providers who can prescribe medication based on clinical judgment. Omzo highlights a Compounded Medication Program as its primary program. The site explicitly states these compounded drugs are not FDA-approved and the FDA has not reviewed them for safety, effectiveness, or quality. Omzo also notes providers may write prescriptions for branded medications, but Omzo does not sell or ship branded drugs.
Hers: Hers offers FDA-approved Wegovy as a brand-name semaglutide option and advertises no compounded medications. The provider describes Wegovy and Zepbound as FDA-approved for weight loss and stresses brand-name availability rather than compounded products.
2. Pricing and membership
Omzo: Lists semaglutide starting at $179 and tirzepatide starting at $279. Pricing appears fee-based for programs that include medication costs collected by Omzo and paid to pharmacies. The site warns that pricing, eligibility, pharmacy, state coverage and renewal terms may change.
Hers: Publishes Wegovy from $149/mo and injectable semaglutide from $199/mo in headline pricing. Hers requires an active Hers Weight Loss Membership to access medication. The membership is $39 for the first month and auto-renews at $149/month thereafter according to captured landing-page details. Hers states total cost includes the standard monthly membership fee and, if prescribed, the cost of medication. Medication is not available without an active membership.
See Hers membership and brand options
3. Ongoing care and program features
Omzo: Emphasizes clinician-guided plans reviewed by licensed U.S. providers with clinician judgment determining prescriptions. Omzo notes clinical services are provided by third party networks of U.S. licensed clinicians who determine eligibility and make the final prescribing decision. Omzo also mentions fast, discreet delivery and FSA and HSA eligibility.
Hers: Highlights a personalized care team with ongoing dose check-ins and a focus on doctor-trusted GLP-1s. Hers states “personalized care team with ongoing dose check-ins” and emphasizes no price markups on brand-name medication. Hers also notes treatment is available only when a licensed clinician determines it is medically appropriate and that prescription availability and state coverage may vary.
Compare Omzo medication options
Comparison table: Omzo vs Hers
| Criteria | Omzo | Hers |
|---|---|---|
| Primary product type | Compounded semaglutide and tirzepatide program; providers may prescribe branded meds | FDA-approved Wegovy and other brand-name GLP-1s; no compounded meds |
| Regulatory note | Compounded medications offered are not FDA-approved | Wegovy and Zepbound are FDA-approved for weight loss |
| Starting price | Semaglutide starting at $179; tirzepatide starting at $279 | Wegovy from $149/mo; injectable semaglutide from $199/mo; membership required |
| Membership requirement | No membership specified; fees include medication costs paid to pharmacies | Active membership required; first month $39 then auto-renews at $149/month |
| Clinical oversight | Clinician-guided plans reviewed by licensed U.S. providers; providers determine eligibility | Personalized care team with ongoing dose check-ins; prescription by licensed clinician |
| Availability and limits | State availability, eligibility, and renewal terms may change | Not available in all 50 states; prescription and eligibility determined by clinician |
Safety and regulatory cautions
Omzo explicitly states compounded medications it offers are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality. Hers emphasizes offering FDA-approved brand-name therapies and that Ozempic and Mounjaro are FDA-approved for diabetes but may be prescribed off-label for weight loss at a clinician’s discretion. Both sources note that prescription availability, state coverage, and eligibility are determined by licensed clinicians and may vary.
Check Hers FDA-approved options
Bottom line and who each is best for
In the Omzo vs Hers comparison the decisive factors are whether you want compounded semaglutide through a clinician-guided compounding program or FDA-approved brand-name GLP-1s with a membership model. Omzo may suit people who want clinician-guided compounded medications with prices starting at $179 and a program that can also result in a prescription for branded meds. Hers may suit people who want FDA-approved Wegovy and brand-name GLP-1s from $149/mo and who accept a required membership to access medication.
Choose Omzo if you want access to a compounded medication program reviewed by licensed U.S. providers and semaglutide starting at $179, and you will confirm eligibility, medication details, renewal terms and state availability before enrollment.
Choose Hers if you prefer FDA-approved Wegovy or other brand-name GLP-1s, are willing to maintain an active Hers Weight Loss Membership to access medication, and accept published starting prices from $149/month.
Start with Omzo clinician-guided care
Primary keyword used: Omzo vs Hers